|
C10ORF119 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.442200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.204800E-01 |
| Normal-vs-Stage2 |
8.273200E-01 |
| Normal-vs-Stage3 |
7.061900E-02 |
| Normal-vs-Stage4 |
2.557200E-01 |
| Stage1-vs-Stage2 |
2.546000E-01 |
| Stage1-vs-Stage3 |
9.624200E-04 |
| Stage1-vs-Stage4 |
1.917650E-02 |
| Stage2-vs-Stage3 |
2.541200E-01 |
| Stage2-vs-Stage4 |
4.953000E-01 |
| Stage3-vs-Stage4 |
6.369200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.805000E-01 |
| Normal-vs-AfricanAmerican |
1.813610E-01 |
| Normal-vs-Asian |
3.993400E-01 |
| Caucasian-vs-AfricanAmerican |
1.547570E-01 |
| Caucasian-vs-Asian |
5.019800E-01 |
| AfricanAmerican-vs-Asian |
2.264400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.773400E-01 |
| Normal-vs-Female |
3.353400E-01 |
| Male-vs-Female |
2.928000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.586000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.982800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.365800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.143500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.580600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.899400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.603400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.280800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.322960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.444220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.102040E-02 |
| Normal-vs-Grade 2 |
5.748500E-02 |
| Normal-vs-Grade 3 |
5.455800E-02 |
| Normal-vs-Grade 4 |
1.073610E-01 |
| Grade 1-vs-Grade 2 |
1.945360E-01 |
| Grade 1-vs-Grade 3 |
1.940190E-03 |
| Grade 1-vs-Grade 4 |
1.058260E-02 |
| Grade 2-vs-Grade 3 |
4.71109999999886E-06 |
| Grade 2-vs-Grade 4 |
1.016380E-03 |
| Grade 3-vs-Grade 4 |
7.613200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.155740E-02 |
| Normal-vs-ccB subtype |
9.877600E-02 |
| ccA subtype-vs-ccB subtype |
1.54041000000049E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.784400E-01 |
| Normal-vs-N1 |
7.397200E-01 |
| N0-vs-N1 |
7.641000E-01 |
|
|
